Med LifeBSE:M 91 Gross Margin % is 79.89% as of Mar. 2026, which is 4% below its 10-year median of 83.07. GuruFocus rates BSE:M with a GF Score™ of 91/100 and a GF Value™ of lei7.82 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 629 Healthcare Providers & Services companies, Med Life ranks better than 86.65% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Med Life's Gross Profit for the
three
months ended in Mar. 2026 was lei682 Mil. Med Life's Revenue for the
three
months ended in Mar. 2026 was lei853 Mil. Therefore, Med Life's Gross Margin % for the quarter that ended in Mar. 2026 was 79.89%.
The historical rank and industry rank for Med Life's Gross Margin % or its related term are showing as below:
BSE:M'
s Gross Margin % Range Over the Past 10 Years
Min: 79.84 Med: 83.07 Max: 84.28
Current: 79.84
During the past 11 years, the highestGross Margin % of Med Life was 84.28%. The lowest was 79.84%. And the median was 83.07%.
BSE:M's Gross Margin % is ranked better than 86.65% of 629
companies
in the Healthcare Providers & Services industry
Industry Median: 40.09
vs BSE:M: 79.84
Med Life had a gross margin of 79.89% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Med Life was -0.40% per year.
Med Life (BSE:M) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Med Life had a gross margin of 79.89% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Med Life Gross Margin % Related Terms
Med Life Gross Margin % Historical Data
* Premium members only.
The historical data trend for Med Life's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Med Life's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Med Life Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Med Life's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Med Life's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Med Life (BSE:M) has a Gross Margin % of 79.89% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Med Life and its competitors. This is near median its historical median of 83.07. Over the past decade, Med Life's Gross Margin % has ranged from 79.84 to 84.28. According to the industry distribution chart, Med Life ranks #84 out of 629 companies in the Healthcare Providers & Services industry, placing it in the top 13.4%.
Is Med Life's Gross Margin % too high?
Med Life's current Gross Margin % of 79.89% is near median its 10-year median of 83.07. Over the past 10 years, this metric has ranged from a low of 79.84 to a high of 84.28. The Healthcare Providers & Services industry median Gross Margin % is 40.09. Med Life's value of 79.89% is 99.3% above this industry median. Based on the distribution chart, Med Life ranks #84 out of 629 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Med Life has a GF Score™ of 91/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Med Life's Gross Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Med Life ranks #84 out of 629 companies for Gross Margin %. This places Med Life in the top 13% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 40.09. Med Life's value of 79.89% is 99.3% above this benchmark. Historically, Med Life's own Gross Margin % has ranged from 79.84 to 84.28 over the past decade. While the company's 10-year median is 83.07 vs. the industry median of 40.09, Med Life has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.09, based on 629 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Med Life's current Gross Margin % of 79.89% is 99.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Med Life and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Med Life's current Gross Margin % is 79.89%, which is near median its own 10-year median of 83.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Life stock overvalued right now?
Based on GuruFocus' analysis, Med Life (BSE:M) is currently considered Significantly Overvalued. The stock's GF Value™ is lei7.82, compared to a current price of lei11.40 — trading 45.8% above its estimated fair value. The current Gross Margin % is 79.89%, which is near median its 10-year median of 83.07 and 99.3% above the Healthcare Providers & Services industry median of 40.09. Med Life's overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Med Life (BSE:M), the current Gross Margin % is 79.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Med Life (BSE:M) Overvalued in 2026?
Based on GuruFocus' analysis, Med Life stock appears to be overvalued.
The current stock price of lei11.40 is trading 45.8% above its estimated GF Value™ of lei7.82.
GuruFocus considers Med Life to be Significantly Overvalued.
Key valuation signals for BSE:M:
Gross Margin %: 79.89% (near median its 10-year median of 83.07)
GF Value™: lei7.82 vs. price of lei11.40 (45.8% above fair value)
Industry Position: 99.3% above the Healthcare Providers & Services median (#84 of 629)
No single metric tells the full story. See the BSE:M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
91GF Score
Get the complete analysis for BSE:M
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSE:M has been successfully added to your 
